4.6 Article

pp32 reduction induces differentiation of TSU-Pr1 cells

期刊

AMERICAN JOURNAL OF PATHOLOGY
卷 164, 期 1, 页码 273-283

出版社

AMER SOC INVESTIGATIVE PATHOLOGY, INC
DOI: 10.1016/S0002-9440(10)63117-3

关键词

-

资金

  1. NATIONAL CANCER INSTITUTE [R01CA054404] Funding Source: NIH RePORTER
  2. NCI NIH HHS [R01 CA 54404] Funding Source: Medline

向作者/读者索取更多资源

pp32 (ANP32A) is a nuclear phosphoprotein expressed as a nomnutated form in self-renewing cell populations and neoplastic cells. Mechanistically, PP32 may regulate pathways important in the process of differentiation as part of separate complexes inhibiting histone acetylation and regulating immediate-early and cytokine mRNA stability. Prostatic adenocarcinomas express pp32 in a differentiation related manner-well-differentiated tumors express lower levels of PP32 than poorly differentiated tumors. In benign prostate, PP32 is expressed in basal cells but not in terminally differentiated glandular cells. Based on these observations, we hypothesized that reduction of pp32 expression might be an important differentiation signal. We used antisense pp32 and RNAi transfection to study the effects of reduced pp32 expression in the TSU-Pr1 carcinoma cell line. pp32 reduction induced Tsu-Pr1 cells to differentiate into neuronal-like cells with associated inhibition of growth. Reduction of pp32 and consequent differentiation were accompanied by a marked reduction in expression of SET, which complexes with PP32, by a marked change in acetylation status of histone 114, and by further differential expression of genes in differentiation pathways. Thus, reduction of PP32 in the undifferentiated TSU-Pr1 neoplastic cell line induces differentiation and thus may be an element of a differentiation control pathway in both normal and neoplastic cells.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.6
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据